Sources Primary Research Interviews Healthcare Practitioners (Endocrinologists, Diabetologists) Clinical Trial Coordinators Pharmaceutical Executives Patient Advocacy Groups Regulatory bodies (e.g., U.S
When CagriSema will make it to the market early next year as the first amylin-based product, it will have the best weight-loss label [of] any marketed product. Novo hopes another study of a higher CagriSema dose will show better results
F.T.M: Conceptualisation, Investigation, Resources, Supervision, Writing Original Draft, Writing Review & Editing, Project administration, Funding acquisition
Their main ability is to donate electrons to the oxidized molecules, being considered as powerful antioxidants (Castelli et al., 2018)
Third, we focus only on gastrointestinal toxicity, and the deep relationship between GLP-1RAs and other system organ classes remains unknown